Every Cure Receives Five-Year, $60 Million Commitment Through TED's Audacious Project to Repurpose Medications for Global Impact. Full Press Release: https://lnkd.in/eCcwt4Vn TED Conferences The Audacious Project
Every Cure
Biotechnology
Philadelphia, PA 7,303 followers
Every Cure is leveraging AI to unlock the full potential of every drug to treat every disease it possibly can.
About us
Every Cure is a nonprofit organization dedicated to unlocking the full potential of every existing medicine to treat every disease possible. Repurposing existing drugs is the fastest and most efficient way to treat diseases with the greatest return on investment for saving lives. However, systemic barriers impede repurposing, so patients suffer while potential treatments are not fully utilized. Every Cure overcomes these barriers to systematically identify and advance promising repurposing opportunities and save lives. Every Cure is taking a revolutionary and disruptive approach to overcome these systemic barriers by developing a comprehensive, open-source data engine to generate predictive efficacy scores for all 3,000 drugs against all 12,000 diseases and rapidly advance treatments to patients. In partnership with academia, industry, and government, Every Cure is integrating proprietary and public data into a comprehensive dataset, optimizing AI ranking algorithms, validating the most promising drug-disease matches, performing trials, and ensuring patient access to effective therapies.
- Website
-
EveryCure.org
External link for Every Cure
- Industry
- Biotechnology
- Company size
- 11-50 employees
- Headquarters
- Philadelphia, PA
- Type
- Nonprofit
- Founded
- 2022
- Specialties
- biotechnology, artificial intelligence, drug development, drug repurposing, non-profit, medicine, and medtech
Locations
-
Primary
Get directions
University of Pennsylvania
Philadelphia, PA, US
Employees at Every Cure
-
Adam Kolom
Biotech Entrepreneur and Investor | Cofounder & CEO, Related Sciences | Cofounder, Parker Institute for Cancer Immunotherapy
-
Craig Lipset
Advisor | Advocate | Educator | Speaker | Mentor | Board Member
-
Grant W Mitchell, MD, MBA
Co-Founder & CEO @ Every Cure
-
David Fajgenbaum, MD, MBA, MSc
Physician-Scientist @ UPenn | National Bestselling Author, Chasing My Cure | Co-Founder @ Every Cure & CDCN
Updates
-
Every Cure reposted this
As we advance in our work, I am excited to share not only Every Cure's progress but also the collective journey we are embarking on together. Please click the link below to read the full letter: https://lnkd.in/evc4X8dZ
-
-
It was so great to see Every Cure Co-founder David Fajgenbaum, MD, MBA, MSc on this panel at the Learn Serve Lead 2024: The AAMC Annual Meeting!
In a session led by Elena Fuentes-Afflick, MD, AAMC chief scientific officer, at Learn Serve Lead 2024 (#AAMC24), Kizzmekia S. Corbett-Helaire, PhD, and David Fajgenbaum, MD, MBA, MSc, shared transformative insights on how thinking beyond traditional limits is saving lives and shaping the future of science. Their breakthroughs — from the development of the mRNA COVID-19 vaccine to drug repurposing for rare diseases — underscore the power of bold, patient-centered science. Join us in exploring their journey and commitment to advancing health care for all. Discover how they’re not only connecting the dots but redefining what’s possible in scientific research. Read more: https://ow.ly/ztTW50U4BZs #MedicalResearch #HealthInnovation #ScientificDiscovery
-
Every Cure reposted this
Physician-Scientist @ UPenn | National Bestselling Author, Chasing My Cure | Co-Founder @ Every Cure & CDCN
Loved being a part of this, Matthew Swift! Thanks for helping to spread the word about my journey #chasingmycure and our work!
Dr. David Fajgenbaum, MD, MBA, MSc found a treatment for the rare disease that he was afflicted with. We talked with him about his personal journey, his pioneering scientific research and the future of patient-led innovation and medicine. Watch this inspiring episode of #TheSwiftHour at the link! 🎥: https://lnkd.in/ekw2CCKC The Swift Hour was filmed at the 14th Annual Concordia Summit in New York.
-
Congrats to David Fajgenbaum, MD, MBA, MSc, and Reece Williams for their impactful article being published in MedPage Today! Their article dives into the life-saving power of drug repurposing, highlighting how existing medications like dexamethasone, tocilizumab, and baricitinib quietly saved countless lives during the COVID-19 pandemic. In a time when new treatments were desperately needed, it was these lesser-known, repurposed drugs that made a difference. Dr. Fajgenbaum and Reece’s insights remind us of the untapped potential sitting on pharmacy shelves, ready to transform lives. With Every Cure on the mission to uncover these hidden opportunities, their work continues to pave the way for thousands of patients with diseases still waiting for effective treatments. https://lnkd.in/eVcxfpTv #DrugRepurposing #MedPageToday #HealthcareInnovation #EveryCure #COVID19
Old Drugs, New Tricks: The Power of Medication Repurposing
medpagetoday.com
-
It was great to see our COO, Mary Zuccato, featured in the Penn State Great Valley Women in Business and Technology Panel!
Associate Director, Career Management Services at Penn State Great Valley School of Graduate Professional Studies
The Penn State Great Valley Coffee & Connections networking event featuring women in business and technology was a huge success yesterday! Our alumni panelists shared their journeys with our students and offered tips and advice for professional growth and career advancement. Thank you to my amazing cohost, Jade Veit, and our wonderful panel: Gina Ellis, Mary Zuccato, Akanksha Anand, Brooke Schneider, MBA, and Nuhamin G Gebremariam
-
-
Every Cure reposted this
Physician-Scientist @ UPenn | National Bestselling Author, Chasing My Cure | Co-Founder @ Every Cure & CDCN
Would you rather repurpose a drug for a rare, deadly condition or for a less severe but more common one? There is no right answer, but in our current system, these questions are often sidelined, as the focus is typically on what’s most profitable. But at Every Cure, we are driven by impact. We’re constantly wrestling with these kinds of questions—whether to prioritize severe, rare diseases or conditions that are more common but less life-threatening. Our team of advisors is guiding us through these decisions, but we want to hear from you. If you were in our shoes, what would be on your mind when making this choice? #DrugRepurposing #HealthcareDecisions #PatientCare #EveryCure #MedicalResearch #ImpactDriven
-
Every Cure reposted this
Physician-Scientist @ UPenn | National Bestselling Author, Chasing My Cure | Co-Founder @ Every Cure & CDCN
At Every Cure, we're on a mission to do something no nonprofit has ever done: unlock the full potential of every drug to treat every disease possible. Achieving this ambitious goal takes more than just a strong tech team and a visionary medical team—it requires a flawless operational backbone. That's where our incredible partners at Beyond Advisers led by Scott M. Curran come in. From day one (even before Every Cure officially launched!), they've been there to support us. With Mary Zuccato as our Chief Operating Officer, we’re ensuring that every detail is meticulously managed and our operations run smoothly. We're so grateful for their dedication and expertise that make our mission possible! #EveryCure #NonprofitInnovation #DrugRepurposing #HealthcareTransformation
-
Every Cure reposted this
I had a fantastic time speaking alongside Paul Howard, PhD, and Randall Rutta on the panel "AI-Fueled Innovation Today and Patient Access Tomorrow" at the Biotechnology Innovation Organization Patient & Health Advocacy Summit in Washington, DC a couple of weeks ago! Engaging in these important conversations about the future of AI in healthcare and how we can make groundbreaking innovations accessible to all patients was inspiring. Thank you to everyone who joined us! #BioPatientSummit #AIInHealthcare #PatientAccess #HealthcareInnovation
-
-
Every Cure reposted this
Physician-Scientist @ UPenn | National Bestselling Author, Chasing My Cure | Co-Founder @ Every Cure & CDCN
It was such an honor to speak at the Google Cloud Cancer Al Symposium in Boston this past week - 20 years after my mom passed away from cancer and I promised her I would dedicate my life to uncovering treatments for cancer and other deadly diseases. Loved being able to share about the lives we've saved and the work we're doing to save many more through Every Cure, Castleman Disease Collaborative Network, and my Center at University of Pennsylvania.
-